38% of the market's growth will originate from North America. US and Canada are the key markets for extracorporeal membrane oxygenation machines in the region. The rising number of new product launches will facilitate the extracorporeal membrane oxygenation machines market growth in North America
Market Dynamics
Factors such as the increasing incidence of respiratory and heart failure and the growing number of transplant procedures will drive the growth of the Extracorporeal Membrane Oxygenation Machines Market. However, high costs associated with cardiac and respiratory procedures might hamper the market growth.
Company Profiles
The extracorporeal membrane oxygenation machines market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The extracorporeal membrane oxygenation machines market report includes information on the product launches, sustainability, and prospects of leading vendors including ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG, and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp.
Few Companies with Key Offerings
- ALung Technologies Inc. - The company offers extracorporeal membrane oxygenation machines that provide ultra low flow, venovenous extracorporeal carbon dioxide removal using a single, 15.5 French dual lumen catheter inserted percutaneously in the femoral or jugular vein and removes 25 to 50 percent of basal metabolic CO2 production at circuit blood flows of 350 to 550 mL per minute, under the brand name of Hemolung RAS.
- Eurosets Srl - The company offers extracorporeal membrane oxygenation machines that are designed to focus on optimal gas microemboli management and of its full coating with phosphorylcholine to work in a unique range of volumes, from less than 250 ml up to 2000 ml., under the brand name of Eurosets.
- Fresenius Medical Care AG and Co - The company offers extracorporeal membrane oxygenation machines that enable gas exchange and circulation, respectively, when standard treatment fails thus providing clinicians time to treat patients, under the brand name of Xenios.
Competitive Analysis
The competitive scenario provided in the extracorporeal membrane oxygenation machines market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
Market Segmentation
- By Modality, the market is classified into Veno-venous and Veno-arterial. The extracorporeal membrane oxygenation machines' market share growth by the Veno-venous segment has been significant.
- By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market.
Related Reports -
Neurodiagnostic and Monitoring Devices -The neurodiagnostic and monitoring devices market size in the US has the potential to grow by USD 443.81 million during 2020-2024.Download a free sample now!
Chemiluminescence Immunoassay Analyzers Market -The chemiluminescence immunoassay (CLIA) analyzers market share is expected to increase by USD 3.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 10.32%. Download a free sample now!
Extracorporeal Membrane Oxygenation Machines Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 10.27% |
Market growth 2021-2025 |
USD 239.83 million |
Market structure |
Fragmented |
YoY growth (%) |
8.87 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 38% |
Key consumer countries |
US, Germany, UK, Canada, China, and France |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., and Terumo Corp. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article